Fulgent Genetics公布2026年第一季度每股收益为-0.36美元，远低于市场预期的-0.11美元，偏差高达227%；营收为7110万美元，亦未达到7268万美元的预期。 营收同比下降3.2%，环比下降14.6%，主要因其最大客户将检测能力转为内部自营，对诊断服务部门造成冲击。 生物制药服务部门营收同比增长43.2%，尽管环比有所下滑；GAAP毛利率达到30.2%，非GAAP毛利率为3 ...

The chemicals flowing through your bloodstream tell a story that your DNA alone cannot. They reflect what you eat, how your ...

While Opus Genetics, Inc. (NASDAQ:IRD) has gained 100.50% year-to-date, analysts continue to see 148.10% upside, helping it ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the ...

How much do your genes and upbringing determine your success? A landmark Norwegian study untangles the complex interplay between genetics, family, and social policies in shaping who thrives. Study: ...

View SOPHiA GENETICS SA SOPH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Opus Genetics (IRD) rated Hold: valuation hinges on AAV gene therapy success. Track LCA5 Phase 3, 2026 data catalysts & ...

The rapid advancement of high-throughput sequencing and multi-omics technologies has transformed genetics into an inherently data-intensive discipline. In ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces today the appointment of Raj Jampa ...

Coordinated launch across Germany and the United Kingdom introduces exclusive Seed Junky genetics into the rapidly growing ...